IL PORTALE per la RICERCA dei DIPARTIMENTI

Cuomo G, Valentini G (2012) ""To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity."

TIRRI R (2012) ". ERYTHEMA YRATUM REPENS AND RHEUMATOID ARTHRITIS:CONNECTED FOR THE FIRST TIMe"

Martinelli E (2012) "2. Using Pharmacokinetic and Pharmacodynamic Data in Decision Making Regarding Drug Development: A Phase I Clinical Trial Evaluating Tyrosine Kinase Inhibitor, AEE788."

Puoti G (2012) "A comparison of Tau and 14-3-3 protein in the diagnosis of Creitzfeldt-Jakob disease"

Cappabianca S (2012) "A computed tomography-based comparative cephalometric analysis of the italian craniofacial pattern through 2700 years"

Esposito K (2012) "A nomogram to estimate the proportion of patients at hemoglobin A1c target <7% with noninsulin antidiabetic drugs in type 2 diabetes: a systematic review of 137 randomized controlled trials with 39 845 patients. "

Troiani T (2012) "A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. "

Melone M (2012) "A synthetic amino acid substitution of Tyr10 in Aß peptide sequence yields a dominant negative variant in amyloidogenesis"

Ciardiello F (2012) "Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials."

Bonini S (2012) "Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs"

Cuomo G, Valentini G (2012) "Candidate gene study in systemic sclerosis identifies a rare and functional variant of TNFAIP3 locus as a risk factor for individual polyautoimmunity. "

Esposito K (2012) "Cardiometabolic risk and female sexual health: the Princeton III summary. "

Valentini G (2012) "Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions."

Cuomo G (2012) "Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry."

Rotondo A (2012) "Detection of small (<=20 mm) pancreatic adenocarcinoma: histologic grading and CT enhancement features."

Ciardiello F (2012) "ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making."

Cuomo G (2012) "Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis."

Ciardiello F, Morgillo F (2012) "First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer: The TORCH Randomized Trial."

Lus G (2012) "Fluctuations of MS births and UV-light exposure."

Esposito K (2012) "HbA(1c) targets for type 2 diabetes: How many, …how far! "

Zingone F (2012) "Increased risk of epilepsy in biopsy-verified celiac disease: a population-based cohort study."

Ciardiello F (2012) "Intrapatient Cetuximab Dose Escalation in Metastatic Colorectal Cancer According to the Grade of Early Skin Reactions: The Randomized EVEREST Study."

Troiani T, Martinelli E, Morgillo F, De Palma R, Ciardiello F (2012) "Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells."

Valentini G (2012) "Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise with the ACR/EULAR working committee for classification criteria in systemic sclerosis. "

Esposito K (2012) "Lifestyle and metabolic approaches to maximizing erectile and vascular health. "

Ciardiello F (2012) "Maintenance treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology."

Martinelli E, Morgillo F (2012) "OPTIMIZING THERAPEUTIC COMBINATIONS OF A SELECTIVE MEK 1/2 INHIBITOR (PIMASERTIB) WITH PI3K/ MTOR INHIBITORS OR WITH MULTI-TARGETED KINASE INHIBITORS IN PIMASERTIB-RESISTANT HUMAN LUNG AND COLORECTAL CANCER CELLS "

Martinelli, Troiani T (2012) "PHASE I/II STUDY OF FOLFIRI PLUS THE MEK1/2 INHIBITOR PIMASERTIB (MSC1936369B) AS SECOND-LINE TREATMENT FOR KRAS MUTATED METASTATIC COLORECTAL CANCER"

Mansi L (2012) "Pharmacokinetic analysis of plasma curves obtained after i.v. injection of the PET radioligand [11C] raclopride provides a likely explanation for rapid radioligand metabolism."

Ciardiello F (2012) "Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination with Vorinostat in KRAS-Mutant Colorectal Cancer Models."

Valentini G (2012) "Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases."

Ciardiello F, Maione P, Gebbia V, Morgillo F, Wierzbicki R (2012) "Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer."

Zappavigna S (2012) "Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells. "

Melone M (2012) "Reduced expression of MECP2 affects cell commitment and maintenance in neurons by triggering senescence, new perspective for Rett syndrome"

Puoti G (2012) "Sporadic human prion diseases: molecular insights and diagnosis"

Cuomo G, Valentini G (2012) "Successful pregnancies but a higher risk of preterm births in systemic sclerosis: An Italian multicentric study. "

Cuomo G (2012) "TGFß receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patients."

De Palma R (2012) "Th17 Cells in Multiple Sclerosis Express Higher Levels of JAK2, Which Increases Their Surface Expression of IFN-¿R2."

Melone M (2012) "The ADAMTS18 gene is responsible for autosomal recessive syndromic retinal dystrophy "

de Magistris L (2012) "The Expression of Caspases is Enhanced in Peripheral Blood Mononuclear Cells of Autism Spectrum Disorder Patients."

Zappavigna S (2012) "The PPAR-¿ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-ß treated pancreatic cancer cells. "

Valentini G (2012) "Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. "

ORDITURA M (2012) "impact of fundoplication on esophageal transit: analysis by combined multichannel intraluminal impedance and manometry."